These observations are supported by recent in vitro studies that demonstrated CIN to exert protection against oxidative stress [52] and mitochondrial dysfunction [53], to have anti-tumor properties [54], and to inhibit Alzheimer disease associated tau aggregation [55]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.